Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

GLOBIN-TERGE

K-Number: K780817 · 1978-07-27

Decision Date1978-07-27
Product Code
DecisionSubstantially Equivalent

Device Summary

GLOBIN-TERGE is the device name listed in this FDA 510(k) record. The listed applicant is Simmler & Son, Inc.. It received FDA 510(k) clearance on 1978-07-27 under 510(k) number K780817. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the GLOBIN-TERGE?

GLOBIN-TERGE is a medical device that received FDA 510(k) clearance on 1978-07-27. The listed applicant is Simmler & Son, Inc.. The 510(k) number is K780817.

When did GLOBIN-TERGE receive FDA 510(k) clearance?

GLOBIN-TERGE received FDA 510(k) clearance on 1978-07-27, under 510(k) number K780817.

Who is the listed applicant for GLOBIN-TERGE?

The FDA 510(k) record lists Simmler & Son, Inc. as the applicant. This does not by itself establish the device manufacturer.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Other records listing Simmler & Son, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 14 devices →

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑